1420367-28-7 Usage
General Description
8-((3,5-difluoro-4-((6-(trifluoromethyl)pyridin-3-yl)oxy)benzyl)oxy)-1-methyl-3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one is a complex chemical compound consisting of a pyrimido[1,6-a]pyrimidine core with multiple functional groups attached. It contains fluorine atoms, a methyl group, and a trifluoromethylpyridin-3-yl moiety, all of which contribute to its structural and chemical properties. The molecule is likely to exhibit a range of biological activities and may have potential applications in medicinal chemistry, drug development, or materials science. Its specific properties and potential uses would need to be determined through further research and testing.
Check Digit Verification of cas no
The CAS Registry Mumber 1420367-28-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,0,3,6 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1420367-28:
(9*1)+(8*4)+(7*2)+(6*0)+(5*3)+(4*6)+(3*7)+(2*2)+(1*8)=127
127 % 10 = 7
So 1420367-28-7 is a valid CAS Registry Number.
1420367-28-7Relevant articles and documents
BICYCLIC PYRIMIDONE COMPOUNDS
-
Paragraph 0602, (2014/07/08)
The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
BICYCLIC PYRIMIDONE COMPOUNDS
-
Page/Page column 67; 68, (2013/03/26)
The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
